Kimberly-Clark, Starbucks Push Deal Boom Toward $4 Trillion (2)

Nov. 4, 2025, 1:42 AM UTC

Dealmakers inked mergers and acquisitions worth more than $80 billion on Monday as they hurtle toward their second best year on record.

Leading the latest haul is Kimberly-Clark Corp., which has agreed to buy struggling Tylenol maker Kenvue Inc. for roughly $40 billion. Kimberly-Clark said the tie-up would allow it to overtake Unilever Plc and become the second-biggest seller of health and wellness products after Procter & Gamble Co. Also in the consumer sector, Starbucks Corp. is selling a majority stake in its China business to private equity firm Boyu Capital at a $4 billion enterprise value.

Investment bankers ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.